Bank7 Corp.
NASDAQ:BSVNBanks - Regional
+$0.18 today
- Market cap
- $612.56M
- Beta
- 0.94
- P/E (TTM)
- 9.7
- EPS (TTM)
- $4.71
- Dividend yield
- 2.35%
Volume 0.04M
Average 0.01M
BSVN Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Bank7 Corp.NASDAQ: BSVN
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock broadly unchanged from a year ago
Common stock stood at $95K at the end of Q1 FY2026, up 1.1% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +1.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 95K USD
- Year-over-year change
- +1.1%
- 4-year CAGR
- +1.1%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 95K | +1.1% |
| FY2024 | 2024-12-31 | 94K | +2.2% |
| FY2023 | 2023-12-31 | 92K | +1.1% |
| FY2022 | 2022-12-31 | 91K | +0.0% |
| FY2021 | 2021-12-31 | 91K | — |
Common Stock vs competitors
How BSVN compares with its peers on the latest reported figures
- BSVN's Mar 2026 common stock of $95K is the 10th highest of the 11 companies compared; the peer median is $6.36M.
- Its year-over-year change of +1.1% is the 3rd highest of 11, against a peer median of +0.0%.
- Common stock amounts to 0.0% of total assets for BSVN, versus a peer median of 0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $420.49M | +34.7% | +10.6% | 9.8% | |
| Mar 2026 | $121.06M | +2.2% | +1.5% | 3.6% | |
| Mar 2026 | $103.02M | -3.1% | -2.9% | 2.7% | |
| Mar 2026 | $25.44M | +0.0% | +0.0% | 1.3% | |
| Mar 2026 | $9.72M | +0.0% | -0.6% | 0.9% | |
| Mar 2026 | $3M | +0.0% | +0.0% | 0.1% | |
| Mar 2026 | $1.72M | +0.0% | +0.0% | 0.1% | |
| Mar 2026 | $180K | -2.2% | +0.8% | 0.0% | |
| Mar 2026 | $96K | +0.0% | +0.7% | 0.0% | |
| Mar 2026 | $95K | +1.1% | +1.4% | 0.0% | |
| Mar 2026 | $78K | -1.3% | -2.0% | 0.0% | |
| Peer median (excluding BSVN) | $6.36M | +0.0% | +0.0% | 0.5% | |
Competitors are the stored peer set for BSVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 198.6M | 114.59M | 198.72M | 240.92M | 244.64M |
| Short-term Investments | 84.81M | 173.17M | 139.69M | 32.22M | 10.46M |
| Net Receivables | 10.52M | 16.44M | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 43.56M |
| Total Current Assets | 293.93M | 304.19M | 338.41M | 273.14M | 298.65M |
| Property, Plant & Equipment (Net) | 17.26M | 13.11M | 14.94M | 18.14M | 21.88M |
| Goodwill | 8.48M | 8.6M | 8.46M | 8.46M | 11.21M |
| Intangible Assets | 1.64M | 1.34M | 1.03M | 878K | 752K |
| Long-term Investments | 1.02B | 1.26B | 1.34B | 1.38B | 55.18M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 9.49M | 0 | 65.68M | 58.45M | (55.18M) |
| Total Non-current Assets | 1.06B | 1.28B | 1.43B | 1.47B | 33.84M |
| Total Assets | 1.35B | 1.58B | 1.77B | 1.74B | 1.96B |
| Account Payables | 5.67M | 9.72M | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 1.05M | 302K | 77K | 594K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22B | 1.43B | 1.59B | 1.52B | 594K |
| Total Current Liabilities | 1.22B | 1.44B | 1.59B | 1.52B | 594K |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | (1.05M) | 9.65M | 11.12M | 1.71B |
| Total Non-current Liabilities | 0 | (1.05M) | 9.65M | 11.12M | 1.71B |
| Total Liabilities | 1.22B | 1.44B | 1.6B | 1.53B | 1.71B |
| Common Stock | 91K | 91K | 92K | 94K | 95K |
| Retained Earnings | 33.15M | 58.05M | 78.96M | 116.28M | 149.71M |
| Accumulated OCI | 144K | (9.3M) | (6.15M) | (4.97M) | (2.55M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 127.41M | 144.1M | 170.33M | 213.21M | 251M |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (198.6M) | (114.59M) | (198.72M) | (240.92M) | (244.64M) |
Bank7 Corp.
NASDAQ:BSVN
Intrinsic Alpha fair value
Locked
Current Price
$57.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.